Methodological Issues in Cytokine Measurement in Schizophrenia

por Koola, Maju Mathew
Publicado 2016

Cytokines in Schizophrenia: Hope or Hype?

por Koola, Maju Mathew
Publicado 2016

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

por Koola, Maju Mathew
Publicado 2016

Psychosocioeconomic Study of Medically Unexplained Physical Symptoms

por Koola, Maju Mathew, Kuttichira, Praveenlal
Publicado 2012

Association of Lyme Disease and Schizoaffective Disorder, Bipolar Type: Is it Inflammation Mediated?

por Mattingley, David William, Koola, Maju Mathew
Publicado 2015

Galantamine-memantine combination effective in dementia: Translate to dementia praecox?

por Koola, Maju Mathew, Parsaik, Ajay K.
Publicado 2018

Dyke-Davidoff-Masson syndrome presenting with bipolar I mania with psychosis

por Kumari, Pooja, Mohsin, Harim, Koola, Maju Mathew
Publicado 2018

Role of Spirituality in the Management of Major Depression and Stress-Related Disorders

por Varghese, Sajoy P., Florentin, Ori David, Koola, Maju Mathew
Publicado 2021

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection

por Wehring, Heidi J., Thedford, Sheryl, Koola, Maju, Kelly, Deanna L.
Publicado 2011

Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity...

por Koola, Maju Mathew, Nikiforuk, Agnieszka, Pillai, Anilkumar, Parsaik, Ajay K.
Publicado 2018

Early Life Stress as a Risk Factor for Substance use Disorders: Clinical and Neurobiological Substrates

por Varghese, Sajoy Purathumuriyil, Montalvo-Ortiz, Janitza L., Csernansky, John G., Eiger, Rodney I., Herrold, Amy A., Koola, Maju Mathew, Dong, Hongxin
Publicado 2015